{"id":"https://openalex.org/W2005681010","doi":"https://doi.org/10.1016/s1359-6349(13)70001-6","title":"Clinical considerations for biosimilar antibodies","display_name":"Clinical considerations for biosimilar antibodies","alternate_titles":[],"publication_year":2013,"publication_date":"2013-12-01","ids":{"openalex":"https://openalex.org/W2005681010","doi":"https://doi.org/10.1016/s1359-6349(13)70001-6","mag":"2005681010","pmid":"https://pubmed.ncbi.nlm.nih.gov/26217160","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4048039"},"language":"en","primary_location":{"id":"doi:10.1016/s1359-6349(13)70001-6","doi":"https://doi.org/10.1016/s1359-6349(13)70001-6","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1359-6349(13)70001-6","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359634913700016/pdf","source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005681010"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S1359634913700016/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069881022","display_name":"H\u00e5kan Mellstedt","orcid":"https://orcid.org/0000-0001-6756-0609","observed_orcids":["https://orcid.org/0000-0001-6756-0609"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"H\u00e5kan Mellstedt","raw_affiliation_strings":["Professor of Oncological Biotherapy, Department of Oncology-Pathology, Karolinska Institute, SE-171 76 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor of Oncological Biotherapy, Department of Oncology-Pathology, Karolinska Institute, SE-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069881022"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":1.4386,"has_fulltext":true,"cited_by_count":66,"citation_normalized_percentile":{"value":0.78976471,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"3","first_page":"1","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.972000002861023},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9919999837875366},{"id":"https://openalex.org/keywords/indication-extrapolation","display_name":"indication extrapolation","score":0.7250000238418579},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9539999961853027},{"id":"https://openalex.org/keywords/product-variation","display_name":"product variation","score":0.921999990940094},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.984000027179718},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.7710000276565552},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9964255094528198},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6077895760536194},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.6003283858299255},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5409442186355591},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.5186775922775269},{"id":"https://openalex.org/C2776050585","wikidata":"https://www.wikidata.org/wiki/Q7439360","display_name":"Scrutiny","level":2,"score":0.4968626797199249},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.4181218445301056},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36778324842453003},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.17648950219154358},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.17483118176460266},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1565035581588745},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.14071139693260193},{"id":"https://openalex.org/C155202549","wikidata":"https://www.wikidata.org/wiki/Q178803","display_name":"International trade","level":1,"score":0.08888715505599976},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.07927334308624268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07812553644180298},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/s1359-6349(13)70001-6","doi":"https://doi.org/10.1016/s1359-6349(13)70001-6","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1359-6349(13)70001-6","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359634913700016/pdf","source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3224091","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4048039","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26217160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26217160","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4048039","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4048039/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJC Suppl","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/s1359-6349(13)70001-6","doi":"https://doi.org/10.1016/s1359-6349(13)70001-6","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1359-6349(13)70001-6","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359634913700016/pdf","source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320318316","display_name":"Celltrion","ror":"https://ror.org/05k84m754"},{"id":"https://openalex.org/F4320332195","display_name":"Samsung","ror":"https://ror.org/04w3jy968"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005681010.pdf","grobid_xml":"https://content.openalex.org/works/W2005681010.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W23380726","https://openalex.org/W1540299321","https://openalex.org/W1601731316","https://openalex.org/W1661968451","https://openalex.org/W1950143140","https://openalex.org/W1964249554","https://openalex.org/W1971471395","https://openalex.org/W1976736354","https://openalex.org/W2003274688","https://openalex.org/W2009744204","https://openalex.org/W2012105765","https://openalex.org/W2015615687","https://openalex.org/W2023419685","https://openalex.org/W2023749561","https://openalex.org/W2024644107","https://openalex.org/W2025122282","https://openalex.org/W2025424758","https://openalex.org/W2051995022","https://openalex.org/W2057175703","https://openalex.org/W2058990783","https://openalex.org/W2067282541","https://openalex.org/W2073935274","https://openalex.org/W2079698561","https://openalex.org/W2083733004","https://openalex.org/W2086286894","https://openalex.org/W2086437884","https://openalex.org/W2093690817","https://openalex.org/W2095628330","https://openalex.org/W2100612316","https://openalex.org/W2101476055","https://openalex.org/W2117738445","https://openalex.org/W2121050884","https://openalex.org/W2141200671","https://openalex.org/W2142289247","https://openalex.org/W2149858688","https://openalex.org/W2162768160","https://openalex.org/W2166900358","https://openalex.org/W2171356556","https://openalex.org/W2317117385","https://openalex.org/W2320641439","https://openalex.org/W2329171559","https://openalex.org/W2329300970","https://openalex.org/W2478829584","https://openalex.org/W2509046259","https://openalex.org/W2577842378","https://openalex.org/W2999405638","https://openalex.org/W4206701382","https://openalex.org/W4251447175"],"related_works":["https://openalex.org/W2047730753","https://openalex.org/W167355880","https://openalex.org/W2333679441","https://openalex.org/W2892118426","https://openalex.org/W2887196941","https://openalex.org/W2321673397","https://openalex.org/W4240681567","https://openalex.org/W1987096590","https://openalex.org/W4378678927","https://openalex.org/W2226209570"],"abstract_inverted_index":{"Biosimilar":[0,38],"agents":[1,23],"are":[2],"approximate":[3],"copies":[4],"of":[5,66,93,98,103,110],"branded":[6],"biologic":[7],"therapies.":[8],"Since":[9],"the":[10,16,28,61,90,96,101,108,114],"first":[11],"biosimilar":[12,34,94],"was":[13],"authorized":[14],"in":[15,19],"European":[17,29],"Union":[18],"2006,":[20],"fifteen":[21],"additional":[22],"have":[24,57],"been":[25,58],"approved":[26],"by":[27],"Medicines":[30],"Agency,":[31],"including":[32],"two":[33],"monoclonal":[35],"antibodies":[36],"(mAbs).":[37],"mAbs":[39],"represent":[40],"a":[41,86],"distinct":[42],"class":[43],"given":[44],"their":[45,77],"large":[46],"molecular":[47],"size,":[48],"complex":[49],"protein":[50],"structure,":[51],"and":[52,64,70,113],"post-translational":[53],"modifications.":[54],"While":[55],"guidelines":[56],"established":[59],"for":[60,116],"development,":[62],"approval,":[63],"use":[65],"biosimilars,":[67],"further":[68],"scrutiny":[69],"discussion":[71],"is":[72],"necessary":[73],"to":[74],"fully":[75],"understand":[76],"potential":[78,115],"impact":[79,102],"on":[80,106],"clinical":[81],"outcomes.":[82],"This":[83],"review":[84],"takes":[85],"critical":[87],"look":[88],"at":[89],"structural":[91],"complexity":[92],"mABs,":[95],"feasibility":[97],"indication":[99],"extrapolation,":[100],"product":[104],"variability":[105],"immunogenicity,":[107],"importance":[109],"comprehensive":[111],"pharmacovigilance,":[112],"ongoing":[117],"pharmacoeconomic":[118],"impact.":[119]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005681010","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
